乌干达2004-2022年艾滋病抗逆转录病毒治疗扩大及避免感染与艾滋病相关死亡的估算
2004年乌干达首位接受PEPFAR支持抗逆转录病毒治疗(ART)者是一名34岁男性;2010至2022年母婴传播替代率从6.4%降至1.5%(降77%),2016至2022年9月病毒载量抑制率从91%升至94%(升3%)。2004-2022年ART扩大避免近50万HIV感染和约60万HIV相关死亡。
要点
- 2004年4月全球首位接受PEPFAR支持ART者为乌干达34岁男性。
- 2004-2022年ART扩大避免近50万HIV感染和约60万HIV相关死亡。
核心结论
- 2004-2022年乌干达ART扩大帮助避免近50万HIV感染和约60万HIV相关死亡。
- 有效ART可降低HIV感染者发病率与死亡率,并在病毒载量抑制至检测不到水平(<200病毒拷贝/mL)后预防性传播和母婴传播。
研究设计与样本
- 基于乌干达2004-2022年PEPFAR支持ART项目数据的效果指标分析。
主要发现
- 母婴传播替代率从2010年6.4%降至2022年1.5%,降77%。
- 病毒载量抑制率(<1000病毒拷贝/mL)从2016年91%升至2022年9月94%,升3%。
- 2004-2022年ART扩大避免近50万HIV感染,其中HIV暴露婴儿感染超23万例,避免约60万HIV相关死亡。
临床怎么用
- 未来工作将聚焦识别所有HIV感染者并快速链接至有效ART。
- PEPFAR承诺继续与乌干达政府、民间社会及其他发展伙伴保持强有力合作,以符合联合国艾滋病规划署(UNAIDS)快速通道战略的可持续方案终结全球艾滋病流行并长期保障已获影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On January 28, 2003, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to address a single disease in history, was announced.* In April 2004, the first person in the world to receive PEPFAR-supported antiretroviral therapy (ART) was a man aged 34 years in Uganda. Effective ART reduces morbidity and mortality among persons with HIV infection (1) and prevents both mother-to-child transmission (MTCT) (2) and sexual transmission once viral load is suppressed to undetectable levels (<200 viral copies/mL) (3). By September 2022, more than 1.3 million persons with HIV infection in Uganda were receiving PEPFAR-supported ART, an increase of approximately 5,000% from September 2004. As indicators of the ART program's effectiveness, a proxy MTCT rate decreased 77%, from 6.4% in 2010 to 1.5% in 2022, and the viral load suppression rate (<1,000 viral copies/mL) increased 3%, from 91% in 2016 to 94% in September 2022. During 2004-2022, ART scale-up helped avert nearly 500,000 HIV infections, including more than 230,000 infections among HIV-exposed infants, and approximately 600,000 HIV-related deaths. Going forward, efforts will focus on identifying all persons with HIV infection and rapidly linking them to effective ART. PEPFAR remains committed to continued strong partnership with the Government of Uganda, civil society, and other development partners toward sustainable solutions aligned with the Joint United Nations Programme on HIV/AIDS (UNAIDS) fast-track strategy to ending the global AIDS epidemic by 2030† and safeguarding impact achieved in the long term.
引用
- Dirlikov E, Kamoga J, Talisuna SA, et al. Scale-Up of HIV Antiretroviral Therapy and Estimation of Averted Infections and HIV-Related Deaths - Uganda, 2004-2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36701255. doi:10.15585/mmwr.mm7204a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。